14 Aug 2014 13:38
Imaginatik Plc
("Imaginatik" or the "Company")
Result of Annual General Meeting and Further re Share Consolidation
Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offering a range of technology products and consultancy, is pleased to announce that at its annual general meeting held earlier today, all resolutions were duly passed.
Accordingly, the proposed share consolidation of the Company's share capital ("Share Capital Reorganisation") will become effective on the record date, being 5.00 p.m. today, 14 August 2014.
Under the Share Capital Reorganisation every 80 existing ordinary shares of 0.0625 pence each will be consolidated into one new ordinary share of 5 pence each ("New Ordinary Shares"), with any fractional entitlements arising from the Share Capital Reorganisation being aggregated and sold in the market on behalf of the relevant shareholders. The rights attaching to the New Ordinary Shares will be identical in all respects to those of the existing ordinary shares.
Application has been made for the 61,745,005 New Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence at 8.00 a.m. on 15 August 2014 with ISIN GB00BP8XY588.
Following the Share Capital Reorganisation there will be 61,745,005 New Ordinary Shares in issue. The Company does not hold any shares in treasury. Therefore the total number of shares with voting rights in the Company following Admission will be 61,745,005. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.
For further information please contact:
Imaginatik plc | Tel: 01329 243243 |
Matt Cooper, Executive Chairman / Shawn Taylor, CFO |
|
finnCap | Tel: 0207 220 0500 |
Charlotte Stranner/ Victoria Bates |
|
Newgate Threadneedle | Tel: 020 7653 9850 |
Caroline Forde / Hilary Millar |
|
About Imaginatik
Imaginatik® is the world's first full-service innovation provider. We have 16 years of experience building innovation into a sustainable competence at some of the world's largest and most respected companies. Through a mix of consulting and advisory, hands-on innovation projects and program management, and our award-winning enterprise software platform, we help clients develop innovation capability into a permanent competitive advantage. Imaginatik is the trusted partner of leading organisations including Blue Cross Blue Shield, CSC, Cargill, The World Bank, Mayo Clinic, The Chubb Group of Insurance Companies, HCA, Dow Chemical and Goodyear.
Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Fareham, UK. For more information visit www.imaginatik.com.